- Johnson & Johnson (JNJ) is recalling 5,000 vials of its Risperdal Consta schizophrenia treatment after tests found that one lot of the injected drug was contaminated with alternaria alternata, a common mold.
- There have so far been no reports of patient complications.
- The recall is the latest in a series for J&J, which last week recalled 200,000 bottles of its Motrin Infants Drops formula due to a risk that they contained tiny plastic particles.
From other sites
at CNBC.com (Fri, 8:17AM)
Video at CNBC.com (Wed, 3:37PM)
Video at CNBC.com (Wed, 1:55PM)
at CNBC.com (Wed, 9:11AM)
Video at CNBC.com (Wed, 8:12AM)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs